Register Login

Sera Prognostics Inc (SERA)

(68% Positive) Sera Prognostics, Inc. (SERA) Announces Enrollment Update for birth Due to Pandemic-Related Challenges, Patient Enrollment Issues, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 7, 2026, 2:14 p.m.

    📋 Sera Prognostics, Inc. (SERA) - Clinical Trial Update

    Filing Date: 2026-01-07

    Accepted: 2026-01-07 09:12:23

    Event Type: Clinical Trial Update

    Event Details:

    Sera Prognostics Inc (SERA) Announces Clinical Trial Update Sera Prognostics Inc (SERA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: birth, Society
    • Diseases/Conditions: asymptomatic women carrying a single baby, every 4
    • Collaboration: PREGNANCY

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: Sera Prognostics Inc
    • CIK: 0001534969
    • Ticker Symbol: SERA
    • Period End Date: 2026-01-07
    • Document Type: 8-K

Search

News categories